Siyu Liu1, Yishi Wang2, and Songtao Ai1
1Shanghai Ninth People's Hospital, Shanghai, China, 2Philips Healthcare, Beijing, China, Beijing, China
Synopsis
Keywords: Muscle, Cancer
Dermatofibrosarcoma
protuberans (DFSP) is a rare low to intermediate grade soft tissue
sarcoma of skin, but the fibrosarcomatous DFSP (FS-DFSP) is a clearly malignant pathological subtype. The
identification of malignant pathological subtypes by radiomics plays an
important role preoperatively. The non-invasive machine learning method based
on T1WI and FS-T2WI imaging is potential prognostic tool by distinguishing
different levels of DFSP pathological subtypes before operation in this study
to provide a new idea for the diagnosis and treatment of DFSP.
Abstract
Introduction
Dermatofibrosarcoma
protuberans(DFSP)is a rare low to intermediate grade soft tissue
sarcoma of skin. DFSP accounts for 0.1% of all malignant tumors and 1.8%-6% of
all soft tissue sarcomas [1-3].
It is most common in adults between 20 and 50 years. There is a slight male
preponderance. DFSP can occur in any part of the body, the most common site of
which is the trunk, followed by the limbs and head and neck [4-6].
DFSP contains
multiple histopathological subtypes, including classic, pigmented, myxoid,
atrophic, sclerotic, fibrosarcomatous and granular cell DFSPs, and giant cell
fibroblastoma [7,8]. The
incidence of fibrosarcomatous DFSP(FS-DFSP)is relatively low, but the local recurrence and
distant metastasis rates are significantly higher than other DFSP variants.
There is a certain risk of death after metastasis which results in generally
poor prognosis of patients, so WHO clearly defines the biological behavior of
FS-DFSP as malignant [9-11].
The treatment approach to DFSP is surgical resection, while FS-DFSP usually
comprehensive treatment of surgery, radiotherapy and chemotherapy and molecular
targeted therapy. Accurate identification of subtypes has a certain value in
determining treatment options and judging prognosis [12].
Recently, the
concept of radiomics has attracted wide attention, which refers to the
extraction of a large number of quantitative image feature data from images to
comprehensively evaluate the various phenotypes of tumors, so as to judge tumor
heterogeneity, clinical stage, histopathological grading, curative effect and
so on [13,14].
At present, there is no single research and report
on the imaging characteristics of DFSP at home and abroad, and most of the
studies focus on soft tissue sarcoma (STS)
[15]. The
purpose of this study is to establish a diagnostic model for classic DFSP and
FS-DFSP image information to explore the feasibility of predicting DFSP
histological subtypes.
Methods
53 DFSPs were retrospectively included in
this study: 9 subjects with FS-DFSP and 44 subjects with classic DFSP (mean
age±standard deviation: 35.58±13.38 years). Their T1-weighted imaging (T1WI)
images and fat-suppressed T2-weighted imaging (FS-T2WI) images constituted the
primary dataset used to train multiple machine learning algorithms for
constructing DFSP histological subtype prediction model. The subjects were
randomly divided into training group and testing group. The training group was
used for machine learning and the testing group was used to evaluate the
performance and generalization of the training model.
All patients were scanned using a 3.0T MR
scanner (Ingenia CX, Philips Healthcare, the Netherlands) including T1WI
(TR/TE, 600/12) and FS-T2WI (TR/TE, 4500/83). Abdominal coil was used for
extremities and trunk lesions. Head and neck coil was used for a few head and
neck lesions.
ROIs were
manually delineated by open-source software (itk-SNAP version 3.8.0) on each
slice of the T1WI images and FS-T2WI images by one musculoskeletal radiologist
with 5 years of professional experience, and each ROI segmentation was tested
by another radiologist with 10 years of professional experience. The ROIs
contained the whole tumor as much as possible.
Least absolute
shrinkage and selection operator (LASSO) was used to select features from
preoperative imaging data. The prediction models of random forest (RF) and k
nearest neighbor (KNN) classifiers were constructed on T1WI and FS-T2WI
respectively by using the extracted imaging features. The prognostic
performance was assessed in training cohort and testing cohort by means of AUC,
sensitivity, specificity and accuracy.
Result
15 imaging
features were selected by using LASSO algorithm. The AUC of RF classifier based
on T1WI was 0.902; sensitivity, 91.2%; specificity, 89.2%; and accuracy, 90.4%.
The AUC of RF classifier based on FS-T2WI was 0.913; sensitivity, 90.7%;
specificity, 91.1%; and accuracy, 88.9%. The AUC of KNN classifier based on
T1WI was 0.798; sensitivity, 88.7%; specificity, 89.7%; and accuracy, 80.1%.
The AUC of KNN classifier based on FS-T2WI was 0.815; sensitivity, 83.5%;
specificity, 86.3%; and accuracy, 82.1%.
Discussion
Machine
learning based on radiomics has certain significance for the identification of
histological subtypes of DFSP. In this study, four groups of data show good
prediction performance, and compared with KNN classifier, RF appears better
performance. RF has
the advantages of fast learning speed, random selection of samples and
features, efficient processing of big data, and high classification accuracy,
so many studies on STS image groups tend to use RF as a feature selection
algorithm or classifier. One
deficiency of this study is that the sample size of FS-DFSP is too small, which
may lead to biased results, and more patient data will be introduced later.
Another one is that only one feature selection algorithm is selected, which may
result in differences in the selection. Other appropriate algorithms will be
added according to the previous literature to make the results more perfect.
Conclusion
This study puts forward for the first time
the application of radiomics to distinguish the
histopathological subtypes of DFSP, which provides a new and effective
assistant diagnostic method for recognizing DFSP variants. The non-invasive
machine learning method based on T1WI and FS-T2WI imaging is potential
prognostic tool by distinguishing different levels of DFSP pathological
subtypes before operation to improve the treatment strategy.Acknowledgements
No acknowledgement found.References
[1] Gloster
H M, Jr.Dermatofibrosarcoma protuberans[J].J Am Acad Dermatol,1996, 35 (3 Pt
1): 355-74; quiz 375-6.
[2] Mendenhall
W M, Zlotecki R A, Scarborough M T.Dermatofibrosarcoma
protuberans[J].Cancer,2004, 101 (11): 2503-2508.
[3] Mujtaba
B, Wang F, Taher A, et al.Dermatofibrosarcoma Protuberans: Pathological and
Imaging Review[J].Curr Probl Diagn Radiol,2021, 50 (2): 236-240.
[4] Chang
C K, Jacobs I A, Salti G I.Outcomes of surgery for dermatofibrosarcoma
protuberans[J].Eur J Surg Oncol,2004, 30 (3): 341-5.
[5] Thway
K, Noujaim J, Jones R L, et al.Dermatofibrosarcoma protuberans: pathology,
genetics, and potential therapeutic strategies[J].Ann Diagn Pathol,2016, 25:
64-71.
[6] Zhang
L, Liu Q Y, Cao Y, et al.Dermatofibrosarcoma Protuberans: Computed Tomography
and Magnetic Resonance Imaging Findings[J].Medicine (Baltimore),2015, 94 (24):
e1001.
[7] Iwasaki
T, Yamamoto H, Oda Y.Current Update on the Molecular Biology of Cutaneous
Sarcoma: Dermatofibrosarcoma Protuberans[J].Curr Treat Options Oncol,2019, 20
(4): 29.
[8] Hao
X, Billings S D, Wu F, et al.Dermatofibrosarcoma Protuberans: Update on the
Diagnosis and Treatment[J].J Clin Med,2020, 9 (6).
[9] Voth
H, Landsberg J, Hinz T, et al.Management of dermatofibrosarcoma protuberans
with fibrosarcomatous transformation: an evidence-based review of the
literature[J].J Eur Acad Dermatol Venereol,2011, 25 (12): 1385-91.
[10] Socoliuc
C, Zurac S, Andrei R, et al.Multiple Histological Subtypes of
Dermatofibrosarcoma Protuberans Occurring in the Same Tumor[J].Rom J Intern
Med,2015, 53 (1): 79-88.
[11] Mentzel
T, Beham A, Katenkamp D, et al.Fibrosarcomatous ("high-grade")
dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical
study of a series of 41 cases with emphasis on prognostic significance[J].Am J
Surg Pathol,1998, 22 (5): 576-87.
[12] Yang
Y, Chen Y, Song J G, et al. Diagnosis and treatment strategy of soft tissue
sarcoma in China[J]. Chinese Journal of Clinical Oncology, 2010, 37 (24): 1385-1389.
[13] Gillies
R J, Kinahan P E, Hricak H.Radiomics: Images Are More than Pictures, They Are
Data[J].Radiology,2016, 278 (2): 563-77.
[14] Mayerhoefer
M E, Materka A, Langs G, et al.Introduction to Radiomics[J].J Nucl Med,2020, 61
(4): 488-495.
[15] Xu
W, Hao D, Hou F, et al.Soft Tissue Sarcoma: Preoperative MRI-Based Radiomics
and Machine Learning May Be Accurate Predictors of Histopathologic Grade[J].AJR
Am J Roentgenol,2020, 215 (4): 963-969.
[16] Fields
B K K, Demirjian N L, Hwang D H, et al.Whole-tumor 3D volumetric MRI-based
radiomics approach for distinguishing between benign and malignant soft tissue
tumors[J].Eur Radiol,2021, 31 (11): 8522-8535.
[17] Peeken
J C, Neumann J, Asadpour R, et al.Prognostic Assessment in High-Grade
Soft-Tissue Sarcoma Patients: A Comparison of Semantic Image Analysis and
Radiomics[J].Cancers (Basel),2021, 13 (8).